PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB) WITH A MAINTAINED VIROLOGICAL RESPONSE TO ENTECAVIR ACHIEVED HBSAG CLEARANCE WHEN SWITCHED TO PEGINTERFERON ALFA-2A THERAPY (THE OSST STUDY)
单位:[1]Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Wuhan 430074, Peoples R China;华中科技大学同济医学院附属同济医院[2]Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China;[3]Fujian Med Univ, Hosp 1, Fuzhou, Peoples R China;[4]Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China;[5]Nanfang Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China;[6]Sichuan Univ, Huaxi Hosp, Chengdu 610064, Peoples R China;四川大学华西医院[7]Zhejiang Univ, Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China;浙江大学医学院附属第一医院[8]Shanghai Roche Pharmaceut Co Ltd, Shanghai, Peoples R China
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Wuhan 430074, Peoples R China;
推荐引用方式(GB/T 7714):
Ning Qin,Han Meifang,Sun Yongtao,et al.PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB) WITH A MAINTAINED VIROLOGICAL RESPONSE TO ENTECAVIR ACHIEVED HBSAG CLEARANCE WHEN SWITCHED TO PEGINTERFERON ALFA-2A THERAPY (THE OSST STUDY)[J].HEPATOLOGY.2011,54:1010A-1011A.
APA:
Ning, Qin,Han, Meifang,Sun, Yongtao,Jiang, Jia-ji,Tan, Deming...&Jiang, Michael.(2011).PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB) WITH A MAINTAINED VIROLOGICAL RESPONSE TO ENTECAVIR ACHIEVED HBSAG CLEARANCE WHEN SWITCHED TO PEGINTERFERON ALFA-2A THERAPY (THE OSST STUDY).HEPATOLOGY,54,
MLA:
Ning, Qin,et al."PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB) WITH A MAINTAINED VIROLOGICAL RESPONSE TO ENTECAVIR ACHIEVED HBSAG CLEARANCE WHEN SWITCHED TO PEGINTERFERON ALFA-2A THERAPY (THE OSST STUDY)".HEPATOLOGY 54.(2011):1010A-1011A